Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2007-10-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Foundation Knee Study - Retrospective
NCT00764894
Retrospective Encore Reverse Shoulder Prosthesis Study
NCT00765037
Efficacy of the CLP® Hip - Retrospective
NCT00764842
A Clinical Investigation of the M2a- 38™ Hip System
NCT00698503
Rejuvenate Modular Outcomes Study
NCT01257568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Linear Hip
Encore Linear Hip System
Encore Linear™ Hip System
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Encore Linear™ Hip System
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* osteoarthritis
* rheumatoid arthritis
* femoral fracture
* correction of a functional deformity
* avascular necrosis of the natural femoral head
* Skeletal maturity
* Patient is likely to be available for evaluation for the duration of the study
* Able and willing to sign the informed consent and follow study procedures
* Patient is not pregnant
* No infection present
* No known materials sensitivity
* Patient is over 18 years of age
Exclusion Criteria
* Infection or sepsis
* Insufficient bone quality that may affect the stability of the implant
* Muscular, neurologic or vascular deficiencies which compromise the affected extremity
* Alcoholism or other addictions
* Prisoners
* High levels of physical activity
* Patient is pregnant
* Loss of ligamentous structures
* Materials sensitivity
* Patient is under 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Encore Medical, L.P.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DJO Surgical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omar Hussamy, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hussamy Orthopedics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hussamy Orthopedics
Vero Beach, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Sponsor Company home page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS - 800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.